Hologic Inc (HOLX)
Cash ratio
| Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 2,160,200 | 2,722,500 | 2,339,500 | 1,170,300 | 701,000 |
| Short-term investments | US$ in thousands | 173,400 | 0 | 31,900 | — | — |
| Total current liabilities | US$ in thousands | 1,037,200 | 1,207,300 | 937,700 | 1,326,800 | 1,239,300 |
| Cash ratio | 2.25 | 2.26 | 2.53 | 0.88 | 0.57 |
September 30, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($2,160,200K
+ $173,400K)
÷ $1,037,200K
= 2.25
Hologic Inc's cash ratio has shown a consistent improvement over the past five years, indicating the company's ability to cover its short-term liabilities with its cash and cash equivalents. The cash ratio has increased steadily from 0.57 in 2020 to 2.25 in 2024. This suggests a stronger liquidity position for the company, with a higher level of cash available to meet its immediate financial obligations. The upward trend signifies an enhanced ability to manage short-term financial challenges, ensuring a more stable financial position for Hologic Inc and potentially reducing the risk of liquidity issues in the future.
Peer comparison
Sep 30, 2024